Solventum Corporation

SOLV Healthcare Medical - Care Facilities NYSE

PDF Back to Search

$79.83

+$0.91 (+1.15%)

Open: $80.24 | High: $81.04 | Low: $79.55 | Prev Close: $78.92

Market Cap: $13.85B

Volume: 223K | Avg: 1.1M

Last updated: January 26, 2026 at 06:05 PM
Featured In

This stock appears in the following dashboards:

Options Activity
Featured
Options Screener
Featured
Options Activity for SOLV
Options Screener Data
Type Strike Expiration Premium Premium Yield Call Vol Put Vol P/C Ratio Rating
N/A $N/A N/A $N/A N/A% N/A N/A N/A N/A/10
View Full Options Screener
Puts/Calls Activity
Type Strike Expiration Premium Volume ROI % Breakeven Delta
N/A $N/A N/A $N/A N/A N/A% $N/A N/A
View Full Options Activity
Investment Rating
A

Buy

Overall Score: 80/100

Rating Breakdown:
DCF Score 5/5
100%
Strong Buy
ROE Score 5/5
100%
Strong Buy
ROA Score 5/5
100%
Strong Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 3/5
60%
Neutral
P/B Score 3/5
60%
Neutral
Add to Watchlist Add to Portfolio
Stock Score Analysis
E

Stock Score: 440

Comprehensive Quality Assessment

Component Breakdown:
Efficiency 25
Financial Health 30
Growth 0
Market Sentiment 20
Risk 5
Lower is better
Valuation 60
Momentum 0
View Full Stock Score Dashboard
Valuation Metrics
Valuation Ratios
P/E Ratio 9.16
P/B Ratio 2.79
P/S Ratio 1.65
EPS $8.71
Beta 0.51
Shares Outstanding 173.45M
Price Range & Moving Averages
52-Week High $88.20
52-Week Low $60.70
SMA 50 $81.16
SMA 200 $74.26
Earnings
Next Earnings February 26, 2026 12:00 PM ET
Financial Ratios
Margins
Gross Margin 54.6%
Operating Margin 7.6%
Net Margin 18.1%
Returns
ROE 41.0%
ROA 10.9%
Liquidity & Leverage
Debt/Equity 1.03
Current Ratio 1.50
Quick Ratio 1.14
Balance Sheet
Total Assets $14.46B
Total Liabilities $11.50B
Total Equity $2.96B
Cash $762.00M
Total Debt $8.01B
Net Debt $7.25B
Income Statement
Revenue $8.25B
Gross Profit $4.59B
Operating Income $1.04B
Net Income $479.00M
EBITDA $1.53B
Revenue/Share $48.20
Cash Flow
Operating CF $1.19B
CapEx $380.00M
Free Cash Flow $805.00M
Book Value/Share $28.61
Tangible Book/Share $-14.33
Equity/Share $28.61
Technical Indicators
RSI (14) 50.00 Neutral
MACD
0.00 Signal: 0.00
Volatility 0.00%
Trading Signal Neutral
Performance & Returns

Insufficient historical data

Insufficient historical data (need 200+ days, have 0)
Sector Comparison (Healthcare)
Compared to 45 peers in Healthcare
Metric SOLV Sector Avg Percentile
P/E Ratio 9.16 35.89 9%
P/B Ratio 2.79 0.21 37%
ROE (%) 41.04% 13.58% 89%
Net Margin (%) 18.14% 9.46% 67%
Stock Score 440 469.0 33%
Percentile: 0% = worst in sector, 100% = best in sector
Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
SOLV $79.83 $0.00 $0.00 $0.00 $0.00 $0.00 50.00 0.00 0.00% 0 Neutral Mixed
Candlestick Patterns

There wasn't any recognizable pattern for the SOLV stock

News Sentiment
📊 Ticker 📰 Headline 💭 Sentiment 📡 Source 🔗 URL
SOLV Anchor Capital Advisors LLC Sells 13,376 Shares of Solventum Corporation $SOLV Neutral defenseworld.net Read More
SOLV Solventum Corporation (NYSE:SOLV) Receives Average Rating of “Hold” from Analysts Neutral defenseworld.net Read More
SOLV Marquette Asset Management, LLC Buys 8 Shares of Solventum Corp (SOLV) Neutral gurufocus.com Read More
SOLV Zicix (OTCMKTS:ZICXD) vs. Solventum (NYSE:SOLV) Head-To-Head Survey Neutral defenseworld.net Read More
SOLV Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? Neutral zacks.com Read More
Recent Insider Trading
Date Insider Position Transaction Shares Price Value
2026-01-02 Gomez Tammy L officer: Chief Human Resources Officer SELL 1332 $79.20 $105494
2025-12-01 Kirberger Marcela A. officer: Chief Legal Affairs Officer SELL 1510 $85.56 $129196
2025-12-01 McMillan Wayde D. officer: Chief Financial Officer SELL 12980 $85.56 $1110569
2025-12-01 Harrington Paul S officer: Chief Supply Chain Officer SELL 4528 $85.56 $387416
Showing last 10 insider transactions. Green badges indicate purchases (bullish signal), red badges indicate sales.
Company Information

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

CEO Bryan C. Hanson
Employees 22000
Country US
IPO Date 2024-04-01
Exchange NYSE
Website https://www.solventum.com
Sector Healthcare
Industry Medical - Care Facilities
Similar Stocks (Healthcare - Medical - Care Facilities)
DVA

DaVita Inc.

Price: $107.56
Change: -0.52%
Market Cap: $7593B
P/E: 11.10
Score: E (485)
View Details
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.

Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.